Global Type 2 Diabetes Medicines Supply, Demand and Key Producers, 2024-2030

Global Type 2 Diabetes Medicines Supply, Demand and Key Producers, 2024-2030

Page: 132

Published Date: 18 Apr 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. The most common medicines used are insulin injection and oral hypoglycemic medications.

The global Type 2 Diabetes Medicines market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. Blood glucose is your main source of energy and comes mainly from the food you eat.Insulin, ahormonemade by thepancreas, helps glucose get into your cells to be used for energy. In type 2 diabetes, your body doesn’t make enough insulin or doesn’t use insulin well. Too much glucose then stays in your blood, and not enough reaches your cells.Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. Blood glucose is your main source of energy and comes mainly from the food you eat. Insulin, a hormone made by the pancreas, helps glucose get into your cells to be used for energy. In type 2 diabetes, your body doesn’t make enough insulin or doesn’t use insulin well. Too much glucose then stays in your blood, and not enough reaches your cells.

This report studies the global Type 2 Diabetes Medicines demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Type 2 Diabetes Medicines, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Type 2 Diabetes Medicines that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Type 2 Diabetes Medicines total market, 2019-2030, (USD Million)
Global Type 2 Diabetes Medicines total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Type 2 Diabetes Medicines total market, key domestic companies, and share, (USD Million)
Global Type 2 Diabetes Medicines revenue by player, revenue and market share 2019-2024, (USD Million)
Global Type 2 Diabetes Medicines total market by Type, CAGR, 2019-2030, (USD Million)
Global Type 2 Diabetes Medicines total market by Channel, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Type 2 Diabetes Medicines market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Type 2 Diabetes Medicines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Channel. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Type 2 Diabetes Medicines Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Type 2 Diabetes Medicines Market, Segmentation by Type
Oral Hypoglycemic Medications
Insulin Injection

Global Type 2 Diabetes Medicines Market, Segmentation by Channel:
Hospital
Retail Pharmacy

Companies Profiled:
Novo Nordisk
Sanofi
Eli Lilly
Merck
AstraZeneca
bayer
Boehringer Ingelheim
Johnson & Johnson
Takeda
Tonghua Dongbao
United Pharmaceuticals
Ganli Pharmaceutical
Biocon
Conker Pharmaceuticals
Jiangsu Wanbang
Geropharm
Wockhardt
Merck Serono
Novartis

Key Questions Answered
1. How big is the global Type 2 Diabetes Medicines market?
2. What is the demand of the global Type 2 Diabetes Medicines market?
3. What is the year over year growth of the global Type 2 Diabetes Medicines market?
4. What is the total value of the global Type 2 Diabetes Medicines market?
5. Who are the Major Players in the global Type 2 Diabetes Medicines market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Type 2 Diabetes Medicines Introduction
1.2 World Type 2 Diabetes Medicines Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Type 2 Diabetes Medicines Total Market by Region (by Headquarter Location)
1.3.1 World Type 2 Diabetes Medicines Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.3 China Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.4 Europe Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.5 Japan Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.6 South Korea Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.7 ASEAN Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.8 India Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Type 2 Diabetes Medicines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends

2 Demand Summary
2.1 World Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.2 World Type 2 Diabetes Medicines Consumption Value by Region
2.2.1 World Type 2 Diabetes Medicines Consumption Value by Region (2019-2024)
2.2.2 World Type 2 Diabetes Medicines Consumption Value Forecast by Region (2025-2030)
2.3 United States Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.4 China Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.5 Europe Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.6 Japan Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.7 South Korea Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.8 ASEAN Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.9 India Type 2 Diabetes Medicines Consumption Value (2019-2030)

3 World Type 2 Diabetes Medicines Companies Competitive Analysis
3.1 World Type 2 Diabetes Medicines Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Type 2 Diabetes Medicines Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Type 2 Diabetes Medicines in 2023
3.2.3 Global Concentration Ratios (CR8) for Type 2 Diabetes Medicines in 2023
3.3 Type 2 Diabetes Medicines Company Evaluation Quadrant
3.4 Type 2 Diabetes Medicines Market: Overall Company Footprint Analysis
3.4.1 Type 2 Diabetes Medicines Market: Region Footprint
3.4.2 Type 2 Diabetes Medicines Market: Company Product Type Footprint
3.4.3 Type 2 Diabetes Medicines Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Type 2 Diabetes Medicines Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Type 2 Diabetes Medicines Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Type 2 Diabetes Medicines Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Type 2 Diabetes Medicines Consumption Value Comparison
4.2.1 United States VS China: Type 2 Diabetes Medicines Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Type 2 Diabetes Medicines Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Type 2 Diabetes Medicines Companies and Market Share, 2019-2024
4.3.1 United States Based Type 2 Diabetes Medicines Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Type 2 Diabetes Medicines Revenue, (2019-2024)
4.4 China Based Companies Type 2 Diabetes Medicines Revenue and Market Share, 2019-2024
4.4.1 China Based Type 2 Diabetes Medicines Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Type 2 Diabetes Medicines Revenue, (2019-2024)
4.5 Rest of World Based Type 2 Diabetes Medicines Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Type 2 Diabetes Medicines Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Type 2 Diabetes Medicines Revenue (2019-2024)

5 Market Analysis by Type
5.1 World Type 2 Diabetes Medicines Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Oral Hypoglycemic Medications
5.2.2 Insulin Injection
5.3 Market Segment by Type
5.3.1 World Type 2 Diabetes Medicines Market Size by Type (2019-2024)
5.3.2 World Type 2 Diabetes Medicines Market Size by Type (2025-2030)
5.3.3 World Type 2 Diabetes Medicines Market Size Market Share by Type (2025-2030)

6 Market Analysis by Channel
6.1 World Type 2 Diabetes Medicines Market Size Overview by Channel: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Channel
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.3 Market Segment by Channel
6.3.1 World Type 2 Diabetes Medicines Market Size by Channel (2019-2024)
6.3.2 World Type 2 Diabetes Medicines Market Size by Channel (2025-2030)
6.3.3 World Type 2 Diabetes Medicines Market Size Market Share by Channel (2019-2030)

7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Details
7.1.2 Novo Nordisk Major Business
7.1.3 Novo Nordisk Type 2 Diabetes Medicines Product and Services
7.1.4 Novo Nordisk Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Novo Nordisk Recent Developments/Updates
7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Type 2 Diabetes Medicines Product and Services
7.2.4 Sanofi Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 Eli Lilly
7.3.1 Eli Lilly Details
7.3.2 Eli Lilly Major Business
7.3.3 Eli Lilly Type 2 Diabetes Medicines Product and Services
7.3.4 Eli Lilly Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Eli Lilly Recent Developments/Updates
7.3.6 Eli Lilly Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Type 2 Diabetes Medicines Product and Services
7.4.4 Merck Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Type 2 Diabetes Medicines Product and Services
7.5.4 AstraZeneca Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 bayer
7.6.1 bayer Details
7.6.2 bayer Major Business
7.6.3 bayer Type 2 Diabetes Medicines Product and Services
7.6.4 bayer Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 bayer Recent Developments/Updates
7.6.6 bayer Competitive Strengths & Weaknesses
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Details
7.7.2 Boehringer Ingelheim Major Business
7.7.3 Boehringer Ingelheim Type 2 Diabetes Medicines Product and Services
7.7.4 Boehringer Ingelheim Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Boehringer Ingelheim Recent Developments/Updates
7.7.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Details
7.8.2 Johnson & Johnson Major Business
7.8.3 Johnson & Johnson Type 2 Diabetes Medicines Product and Services
7.8.4 Johnson & Johnson Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Johnson & Johnson Recent Developments/Updates
7.8.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.9 Takeda
7.9.1 Takeda Details
7.9.2 Takeda Major Business
7.9.3 Takeda Type 2 Diabetes Medicines Product and Services
7.9.4 Takeda Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Takeda Recent Developments/Updates
7.9.6 Takeda Competitive Strengths & Weaknesses
7.10 Tonghua Dongbao
7.10.1 Tonghua Dongbao Details
7.10.2 Tonghua Dongbao Major Business
7.10.3 Tonghua Dongbao Type 2 Diabetes Medicines Product and Services
7.10.4 Tonghua Dongbao Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Tonghua Dongbao Recent Developments/Updates
7.10.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.11 United Pharmaceuticals
7.11.1 United Pharmaceuticals Details
7.11.2 United Pharmaceuticals Major Business
7.11.3 United Pharmaceuticals Type 2 Diabetes Medicines Product and Services
7.11.4 United Pharmaceuticals Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 United Pharmaceuticals Recent Developments/Updates
7.11.6 United Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Ganli Pharmaceutical
7.12.1 Ganli Pharmaceutical Details
7.12.2 Ganli Pharmaceutical Major Business
7.12.3 Ganli Pharmaceutical Type 2 Diabetes Medicines Product and Services
7.12.4 Ganli Pharmaceutical Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Ganli Pharmaceutical Recent Developments/Updates
7.12.6 Ganli Pharmaceutical Competitive Strengths & Weaknesses
7.13 Biocon
7.13.1 Biocon Details
7.13.2 Biocon Major Business
7.13.3 Biocon Type 2 Diabetes Medicines Product and Services
7.13.4 Biocon Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Biocon Recent Developments/Updates
7.13.6 Biocon Competitive Strengths & Weaknesses
7.14 Conker Pharmaceuticals
7.14.1 Conker Pharmaceuticals Details
7.14.2 Conker Pharmaceuticals Major Business
7.14.3 Conker Pharmaceuticals Type 2 Diabetes Medicines Product and Services
7.14.4 Conker Pharmaceuticals Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Conker Pharmaceuticals Recent Developments/Updates
7.14.6 Conker Pharmaceuticals Competitive Strengths & Weaknesses
7.15 Jiangsu Wanbang
7.15.1 Jiangsu Wanbang Details
7.15.2 Jiangsu Wanbang Major Business
7.15.3 Jiangsu Wanbang Type 2 Diabetes Medicines Product and Services
7.15.4 Jiangsu Wanbang Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Jiangsu Wanbang Recent Developments/Updates
7.15.6 Jiangsu Wanbang Competitive Strengths & Weaknesses
7.16 Geropharm
7.16.1 Geropharm Details
7.16.2 Geropharm Major Business
7.16.3 Geropharm Type 2 Diabetes Medicines Product and Services
7.16.4 Geropharm Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Geropharm Recent Developments/Updates
7.16.6 Geropharm Competitive Strengths & Weaknesses
7.17 Wockhardt
7.17.1 Wockhardt Details
7.17.2 Wockhardt Major Business
7.17.3 Wockhardt Type 2 Diabetes Medicines Product and Services
7.17.4 Wockhardt Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 Wockhardt Recent Developments/Updates
7.17.6 Wockhardt Competitive Strengths & Weaknesses
7.18 Merck Serono
7.18.1 Merck Serono Details
7.18.2 Merck Serono Major Business
7.18.3 Merck Serono Type 2 Diabetes Medicines Product and Services
7.18.4 Merck Serono Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Merck Serono Recent Developments/Updates
7.18.6 Merck Serono Competitive Strengths & Weaknesses
7.19 Novartis
7.19.1 Novartis Details
7.19.2 Novartis Major Business
7.19.3 Novartis Type 2 Diabetes Medicines Product and Services
7.19.4 Novartis Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Novartis Recent Developments/Updates
7.19.6 Novartis Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Type 2 Diabetes Medicines Industry Chain
8.2 Type 2 Diabetes Medicines Upstream Analysis
8.3 Type 2 Diabetes Medicines Midstream Analysis
8.4 Type 2 Diabetes Medicines Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Type 2 Diabetes Medicines Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Type 2 Diabetes Medicines Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Type 2 Diabetes Medicines Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Type 2 Diabetes Medicines Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Type 2 Diabetes Medicines Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Type 2 Diabetes Medicines Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Type 2 Diabetes Medicines Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Type 2 Diabetes Medicines Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Type 2 Diabetes Medicines Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Type 2 Diabetes Medicines Players in 2023
Table 12. World Type 2 Diabetes Medicines Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Type 2 Diabetes Medicines Company Evaluation Quadrant
Table 14. Head Office of Key Type 2 Diabetes Medicines Players
Table 15. Type 2 Diabetes Medicines Market: Company Product Type Footprint
Table 16. Type 2 Diabetes Medicines Market: Company Product Application Footprint
Table 17. Type 2 Diabetes Medicines Mergers & Acquisitions Activity
Table 18. United States VS China Type 2 Diabetes Medicines Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Type 2 Diabetes Medicines Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Type 2 Diabetes Medicines Companies, Headquarters (States, Country)
Table 21. United States Based Companies Type 2 Diabetes Medicines Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Type 2 Diabetes Medicines Revenue Market Share (2019-2024)
Table 23. China Based Type 2 Diabetes Medicines Companies, Headquarters (Province, Country)
Table 24. China Based Companies Type 2 Diabetes Medicines Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Type 2 Diabetes Medicines Revenue Market Share (2019-2024)
Table 26. Rest of World Based Type 2 Diabetes Medicines Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Type 2 Diabetes Medicines Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Type 2 Diabetes Medicines Revenue Market Share (2019-2024)
Table 29. World Type 2 Diabetes Medicines Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Type 2 Diabetes Medicines Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Type 2 Diabetes Medicines Market Size by Type (2025-2030) & (USD Million)
Table 32. World Type 2 Diabetes Medicines Market Size by Channel, (USD Million), 2019 & 2023 & 2030
Table 33. World Type 2 Diabetes Medicines Market Size by Channel (2019-2024) & (USD Million)
Table 34. World Type 2 Diabetes Medicines Market Size by Channel (2025-2030) & (USD Million)
Table 35. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 36. Novo Nordisk Major Business
Table 37. Novo Nordisk Type 2 Diabetes Medicines Product and Services
Table 38. Novo Nordisk Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Novo Nordisk Recent Developments/Updates
Table 40. Novo Nordisk Competitive Strengths & Weaknesses
Table 41. Sanofi Basic Information, Manufacturing Base and Competitors
Table 42. Sanofi Major Business
Table 43. Sanofi Type 2 Diabetes Medicines Product and Services
Table 44. Sanofi Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Sanofi Recent Developments/Updates
Table 46. Sanofi Competitive Strengths & Weaknesses
Table 47. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 48. Eli Lilly Major Business
Table 49. Eli Lilly Type 2 Diabetes Medicines Product and Services
Table 50. Eli Lilly Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Eli Lilly Recent Developments/Updates
Table 52. Eli Lilly Competitive Strengths & Weaknesses
Table 53. Merck Basic Information, Manufacturing Base and Competitors
Table 54. Merck Major Business
Table 55. Merck Type 2 Diabetes Medicines Product and Services
Table 56. Merck Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Merck Recent Developments/Updates
Table 58. Merck Competitive Strengths & Weaknesses
Table 59. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 60. AstraZeneca Major Business
Table 61. AstraZeneca Type 2 Diabetes Medicines Product and Services
Table 62. AstraZeneca Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. AstraZeneca Recent Developments/Updates
Table 64. AstraZeneca Competitive Strengths & Weaknesses
Table 65. bayer Basic Information, Manufacturing Base and Competitors
Table 66. bayer Major Business
Table 67. bayer Type 2 Diabetes Medicines Product and Services
Table 68. bayer Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. bayer Recent Developments/Updates
Table 70. bayer Competitive Strengths & Weaknesses
Table 71. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 72. Boehringer Ingelheim Major Business
Table 73. Boehringer Ingelheim Type 2 Diabetes Medicines Product and Services
Table 74. Boehringer Ingelheim Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Boehringer Ingelheim Recent Developments/Updates
Table 76. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 77. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 78. Johnson & Johnson Major Business
Table 79. Johnson & Johnson Type 2 Diabetes Medicines Product and Services
Table 80. Johnson & Johnson Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Johnson & Johnson Recent Developments/Updates
Table 82. Johnson & Johnson Competitive Strengths & Weaknesses
Table 83. Takeda Basic Information, Manufacturing Base and Competitors
Table 84. Takeda Major Business
Table 85. Takeda Type 2 Diabetes Medicines Product and Services
Table 86. Takeda Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Takeda Recent Developments/Updates
Table 88. Takeda Competitive Strengths & Weaknesses
Table 89. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 90. Tonghua Dongbao Major Business
Table 91. Tonghua Dongbao Type 2 Diabetes Medicines Product and Services
Table 92. Tonghua Dongbao Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Tonghua Dongbao Recent Developments/Updates
Table 94. Tonghua Dongbao Competitive Strengths & Weaknesses
Table 95. United Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 96. United Pharmaceuticals Major Business
Table 97. United Pharmaceuticals Type 2 Diabetes Medicines Product and Services
Table 98. United Pharmaceuticals Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. United Pharmaceuticals Recent Developments/Updates
Table 100. United Pharmaceuticals Competitive Strengths & Weaknesses
Table 101. Ganli Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 102. Ganli Pharmaceutical Major Business
Table 103. Ganli Pharmaceutical Type 2 Diabetes Medicines Product and Services
Table 104. Ganli Pharmaceutical Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Ganli Pharmaceutical Recent Developments/Updates
Table 106. Ganli Pharmaceutical Competitive Strengths & Weaknesses
Table 107. Biocon Basic Information, Manufacturing Base and Competitors
Table 108. Biocon Major Business
Table 109. Biocon Type 2 Diabetes Medicines Product and Services
Table 110. Biocon Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Biocon Recent Developments/Updates
Table 112. Biocon Competitive Strengths & Weaknesses
Table 113. Conker Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 114. Conker Pharmaceuticals Major Business
Table 115. Conker Pharmaceuticals Type 2 Diabetes Medicines Product and Services
Table 116. Conker Pharmaceuticals Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Conker Pharmaceuticals Recent Developments/Updates
Table 118. Conker Pharmaceuticals Competitive Strengths & Weaknesses
Table 119. Jiangsu Wanbang Basic Information, Manufacturing Base and Competitors
Table 120. Jiangsu Wanbang Major Business
Table 121. Jiangsu Wanbang Type 2 Diabetes Medicines Product and Services
Table 122. Jiangsu Wanbang Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Jiangsu Wanbang Recent Developments/Updates
Table 124. Jiangsu Wanbang Competitive Strengths & Weaknesses
Table 125. Geropharm Basic Information, Manufacturing Base and Competitors
Table 126. Geropharm Major Business
Table 127. Geropharm Type 2 Diabetes Medicines Product and Services
Table 128. Geropharm Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Geropharm Recent Developments/Updates
Table 130. Geropharm Competitive Strengths & Weaknesses
Table 131. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 132. Wockhardt Major Business
Table 133. Wockhardt Type 2 Diabetes Medicines Product and Services
Table 134. Wockhardt Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. Wockhardt Recent Developments/Updates
Table 136. Wockhardt Competitive Strengths & Weaknesses
Table 137. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 138. Merck Serono Major Business
Table 139. Merck Serono Type 2 Diabetes Medicines Product and Services
Table 140. Merck Serono Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Merck Serono Recent Developments/Updates
Table 142. Merck Serono Competitive Strengths & Weaknesses
Table 143. Novartis Basic Information, Manufacturing Base and Competitors
Table 144. Novartis Major Business
Table 145. Novartis Type 2 Diabetes Medicines Product and Services
Table 146. Novartis Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. Novartis Recent Developments/Updates
Table 148. Novartis Competitive Strengths & Weaknesses
Table 149. Global Key Players of Type 2 Diabetes Medicines Upstream (Raw Materials)
Table 150. Global Type 2 Diabetes Medicines Typical Customers


List of Figures
Figure 1. Type 2 Diabetes Medicines Picture
Figure 2. World Type 2 Diabetes Medicines Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Type 2 Diabetes Medicines Total Revenue (2019-2030) & (USD Million)
Figure 4. World Type 2 Diabetes Medicines Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Type 2 Diabetes Medicines Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 13. Type 2 Diabetes Medicines Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 16. World Type 2 Diabetes Medicines Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 18. China Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 23. India Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Type 2 Diabetes Medicines by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Type 2 Diabetes Medicines Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Type 2 Diabetes Medicines Markets in 2023
Figure 27. United States VS China: Type 2 Diabetes Medicines Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Type 2 Diabetes Medicines Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Type 2 Diabetes Medicines Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Type 2 Diabetes Medicines Market Size Market Share by Type in 2023
Figure 31. Oral Hypoglycemic Medications
Figure 32. Insulin Injection
Figure 33. World Type 2 Diabetes Medicines Market Size Market Share by Type (2019-2030)
Figure 34. World Type 2 Diabetes Medicines Market Size by Channel, (USD Million), 2019 & 2023 & 2030
Figure 35. World Type 2 Diabetes Medicines Market Size Market Share by Channel in 2023
Figure 36. Hospital
Figure 37. Retail Pharmacy
Figure 38. World Type 2 Diabetes Medicines Market Size Market Share by Channel (2019-2030)
Figure 39. Type 2 Diabetes Medicines Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Novo Nordisk
Sanofi
Eli Lilly
Merck
AstraZeneca
bayer
Boehringer Ingelheim
Johnson & Johnson
Takeda
Tonghua Dongbao
United Pharmaceuticals
Ganli Pharmaceutical
Biocon
Conker Pharmaceuticals
Jiangsu Wanbang
Geropharm
Wockhardt
Merck Serono
Novartis
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Type 2 Diabetes Medicines Supply, Demand and Key Producers, 2024-2030

Global Type 2 Diabetes Medicines Supply, Demand and Key Producers, 2024-2030

Page: 132

Published Date: 18 Apr 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. The most common medicines used are insulin injection and oral hypoglycemic medications.

The global Type 2 Diabetes Medicines market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. Blood glucose is your main source of energy and comes mainly from the food you eat.Insulin, ahormonemade by thepancreas, helps glucose get into your cells to be used for energy. In type 2 diabetes, your body doesn’t make enough insulin or doesn’t use insulin well. Too much glucose then stays in your blood, and not enough reaches your cells.Type 2 diabetes, the most common type of diabetes, is a disease that occurs when your blood glucose, also called blood sugar, is too high. Blood glucose is your main source of energy and comes mainly from the food you eat. Insulin, a hormone made by the pancreas, helps glucose get into your cells to be used for energy. In type 2 diabetes, your body doesn’t make enough insulin or doesn’t use insulin well. Too much glucose then stays in your blood, and not enough reaches your cells.

This report studies the global Type 2 Diabetes Medicines demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Type 2 Diabetes Medicines, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Type 2 Diabetes Medicines that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Type 2 Diabetes Medicines total market, 2019-2030, (USD Million)
Global Type 2 Diabetes Medicines total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Type 2 Diabetes Medicines total market, key domestic companies, and share, (USD Million)
Global Type 2 Diabetes Medicines revenue by player, revenue and market share 2019-2024, (USD Million)
Global Type 2 Diabetes Medicines total market by Type, CAGR, 2019-2030, (USD Million)
Global Type 2 Diabetes Medicines total market by Channel, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Type 2 Diabetes Medicines market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Type 2 Diabetes Medicines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Channel. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Type 2 Diabetes Medicines Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Type 2 Diabetes Medicines Market, Segmentation by Type
Oral Hypoglycemic Medications
Insulin Injection

Global Type 2 Diabetes Medicines Market, Segmentation by Channel:
Hospital
Retail Pharmacy

Companies Profiled:
Novo Nordisk
Sanofi
Eli Lilly
Merck
AstraZeneca
bayer
Boehringer Ingelheim
Johnson & Johnson
Takeda
Tonghua Dongbao
United Pharmaceuticals
Ganli Pharmaceutical
Biocon
Conker Pharmaceuticals
Jiangsu Wanbang
Geropharm
Wockhardt
Merck Serono
Novartis

Key Questions Answered
1. How big is the global Type 2 Diabetes Medicines market?
2. What is the demand of the global Type 2 Diabetes Medicines market?
3. What is the year over year growth of the global Type 2 Diabetes Medicines market?
4. What is the total value of the global Type 2 Diabetes Medicines market?
5. Who are the Major Players in the global Type 2 Diabetes Medicines market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Type 2 Diabetes Medicines Introduction
1.2 World Type 2 Diabetes Medicines Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Type 2 Diabetes Medicines Total Market by Region (by Headquarter Location)
1.3.1 World Type 2 Diabetes Medicines Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.3 China Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.4 Europe Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.5 Japan Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.6 South Korea Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.7 ASEAN Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.3.8 India Based Company Type 2 Diabetes Medicines Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Type 2 Diabetes Medicines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends

2 Demand Summary
2.1 World Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.2 World Type 2 Diabetes Medicines Consumption Value by Region
2.2.1 World Type 2 Diabetes Medicines Consumption Value by Region (2019-2024)
2.2.2 World Type 2 Diabetes Medicines Consumption Value Forecast by Region (2025-2030)
2.3 United States Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.4 China Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.5 Europe Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.6 Japan Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.7 South Korea Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.8 ASEAN Type 2 Diabetes Medicines Consumption Value (2019-2030)
2.9 India Type 2 Diabetes Medicines Consumption Value (2019-2030)

3 World Type 2 Diabetes Medicines Companies Competitive Analysis
3.1 World Type 2 Diabetes Medicines Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Type 2 Diabetes Medicines Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Type 2 Diabetes Medicines in 2023
3.2.3 Global Concentration Ratios (CR8) for Type 2 Diabetes Medicines in 2023
3.3 Type 2 Diabetes Medicines Company Evaluation Quadrant
3.4 Type 2 Diabetes Medicines Market: Overall Company Footprint Analysis
3.4.1 Type 2 Diabetes Medicines Market: Region Footprint
3.4.2 Type 2 Diabetes Medicines Market: Company Product Type Footprint
3.4.3 Type 2 Diabetes Medicines Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Type 2 Diabetes Medicines Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Type 2 Diabetes Medicines Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Type 2 Diabetes Medicines Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Type 2 Diabetes Medicines Consumption Value Comparison
4.2.1 United States VS China: Type 2 Diabetes Medicines Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Type 2 Diabetes Medicines Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Type 2 Diabetes Medicines Companies and Market Share, 2019-2024
4.3.1 United States Based Type 2 Diabetes Medicines Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Type 2 Diabetes Medicines Revenue, (2019-2024)
4.4 China Based Companies Type 2 Diabetes Medicines Revenue and Market Share, 2019-2024
4.4.1 China Based Type 2 Diabetes Medicines Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Type 2 Diabetes Medicines Revenue, (2019-2024)
4.5 Rest of World Based Type 2 Diabetes Medicines Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Type 2 Diabetes Medicines Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Type 2 Diabetes Medicines Revenue (2019-2024)

5 Market Analysis by Type
5.1 World Type 2 Diabetes Medicines Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Oral Hypoglycemic Medications
5.2.2 Insulin Injection
5.3 Market Segment by Type
5.3.1 World Type 2 Diabetes Medicines Market Size by Type (2019-2024)
5.3.2 World Type 2 Diabetes Medicines Market Size by Type (2025-2030)
5.3.3 World Type 2 Diabetes Medicines Market Size Market Share by Type (2025-2030)

6 Market Analysis by Channel
6.1 World Type 2 Diabetes Medicines Market Size Overview by Channel: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Channel
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.3 Market Segment by Channel
6.3.1 World Type 2 Diabetes Medicines Market Size by Channel (2019-2024)
6.3.2 World Type 2 Diabetes Medicines Market Size by Channel (2025-2030)
6.3.3 World Type 2 Diabetes Medicines Market Size Market Share by Channel (2019-2030)

7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Details
7.1.2 Novo Nordisk Major Business
7.1.3 Novo Nordisk Type 2 Diabetes Medicines Product and Services
7.1.4 Novo Nordisk Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Novo Nordisk Recent Developments/Updates
7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Type 2 Diabetes Medicines Product and Services
7.2.4 Sanofi Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 Eli Lilly
7.3.1 Eli Lilly Details
7.3.2 Eli Lilly Major Business
7.3.3 Eli Lilly Type 2 Diabetes Medicines Product and Services
7.3.4 Eli Lilly Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Eli Lilly Recent Developments/Updates
7.3.6 Eli Lilly Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck Type 2 Diabetes Medicines Product and Services
7.4.4 Merck Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 AstraZeneca
7.5.1 AstraZeneca Details
7.5.2 AstraZeneca Major Business
7.5.3 AstraZeneca Type 2 Diabetes Medicines Product and Services
7.5.4 AstraZeneca Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 AstraZeneca Recent Developments/Updates
7.5.6 AstraZeneca Competitive Strengths & Weaknesses
7.6 bayer
7.6.1 bayer Details
7.6.2 bayer Major Business
7.6.3 bayer Type 2 Diabetes Medicines Product and Services
7.6.4 bayer Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 bayer Recent Developments/Updates
7.6.6 bayer Competitive Strengths & Weaknesses
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Details
7.7.2 Boehringer Ingelheim Major Business
7.7.3 Boehringer Ingelheim Type 2 Diabetes Medicines Product and Services
7.7.4 Boehringer Ingelheim Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Boehringer Ingelheim Recent Developments/Updates
7.7.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Details
7.8.2 Johnson & Johnson Major Business
7.8.3 Johnson & Johnson Type 2 Diabetes Medicines Product and Services
7.8.4 Johnson & Johnson Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Johnson & Johnson Recent Developments/Updates
7.8.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.9 Takeda
7.9.1 Takeda Details
7.9.2 Takeda Major Business
7.9.3 Takeda Type 2 Diabetes Medicines Product and Services
7.9.4 Takeda Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Takeda Recent Developments/Updates
7.9.6 Takeda Competitive Strengths & Weaknesses
7.10 Tonghua Dongbao
7.10.1 Tonghua Dongbao Details
7.10.2 Tonghua Dongbao Major Business
7.10.3 Tonghua Dongbao Type 2 Diabetes Medicines Product and Services
7.10.4 Tonghua Dongbao Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Tonghua Dongbao Recent Developments/Updates
7.10.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.11 United Pharmaceuticals
7.11.1 United Pharmaceuticals Details
7.11.2 United Pharmaceuticals Major Business
7.11.3 United Pharmaceuticals Type 2 Diabetes Medicines Product and Services
7.11.4 United Pharmaceuticals Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 United Pharmaceuticals Recent Developments/Updates
7.11.6 United Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Ganli Pharmaceutical
7.12.1 Ganli Pharmaceutical Details
7.12.2 Ganli Pharmaceutical Major Business
7.12.3 Ganli Pharmaceutical Type 2 Diabetes Medicines Product and Services
7.12.4 Ganli Pharmaceutical Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Ganli Pharmaceutical Recent Developments/Updates
7.12.6 Ganli Pharmaceutical Competitive Strengths & Weaknesses
7.13 Biocon
7.13.1 Biocon Details
7.13.2 Biocon Major Business
7.13.3 Biocon Type 2 Diabetes Medicines Product and Services
7.13.4 Biocon Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Biocon Recent Developments/Updates
7.13.6 Biocon Competitive Strengths & Weaknesses
7.14 Conker Pharmaceuticals
7.14.1 Conker Pharmaceuticals Details
7.14.2 Conker Pharmaceuticals Major Business
7.14.3 Conker Pharmaceuticals Type 2 Diabetes Medicines Product and Services
7.14.4 Conker Pharmaceuticals Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Conker Pharmaceuticals Recent Developments/Updates
7.14.6 Conker Pharmaceuticals Competitive Strengths & Weaknesses
7.15 Jiangsu Wanbang
7.15.1 Jiangsu Wanbang Details
7.15.2 Jiangsu Wanbang Major Business
7.15.3 Jiangsu Wanbang Type 2 Diabetes Medicines Product and Services
7.15.4 Jiangsu Wanbang Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Jiangsu Wanbang Recent Developments/Updates
7.15.6 Jiangsu Wanbang Competitive Strengths & Weaknesses
7.16 Geropharm
7.16.1 Geropharm Details
7.16.2 Geropharm Major Business
7.16.3 Geropharm Type 2 Diabetes Medicines Product and Services
7.16.4 Geropharm Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 Geropharm Recent Developments/Updates
7.16.6 Geropharm Competitive Strengths & Weaknesses
7.17 Wockhardt
7.17.1 Wockhardt Details
7.17.2 Wockhardt Major Business
7.17.3 Wockhardt Type 2 Diabetes Medicines Product and Services
7.17.4 Wockhardt Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 Wockhardt Recent Developments/Updates
7.17.6 Wockhardt Competitive Strengths & Weaknesses
7.18 Merck Serono
7.18.1 Merck Serono Details
7.18.2 Merck Serono Major Business
7.18.3 Merck Serono Type 2 Diabetes Medicines Product and Services
7.18.4 Merck Serono Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Merck Serono Recent Developments/Updates
7.18.6 Merck Serono Competitive Strengths & Weaknesses
7.19 Novartis
7.19.1 Novartis Details
7.19.2 Novartis Major Business
7.19.3 Novartis Type 2 Diabetes Medicines Product and Services
7.19.4 Novartis Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Novartis Recent Developments/Updates
7.19.6 Novartis Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Type 2 Diabetes Medicines Industry Chain
8.2 Type 2 Diabetes Medicines Upstream Analysis
8.3 Type 2 Diabetes Medicines Midstream Analysis
8.4 Type 2 Diabetes Medicines Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Type 2 Diabetes Medicines Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Type 2 Diabetes Medicines Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Type 2 Diabetes Medicines Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Type 2 Diabetes Medicines Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Type 2 Diabetes Medicines Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Type 2 Diabetes Medicines Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Type 2 Diabetes Medicines Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Type 2 Diabetes Medicines Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Type 2 Diabetes Medicines Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Type 2 Diabetes Medicines Players in 2023
Table 12. World Type 2 Diabetes Medicines Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Type 2 Diabetes Medicines Company Evaluation Quadrant
Table 14. Head Office of Key Type 2 Diabetes Medicines Players
Table 15. Type 2 Diabetes Medicines Market: Company Product Type Footprint
Table 16. Type 2 Diabetes Medicines Market: Company Product Application Footprint
Table 17. Type 2 Diabetes Medicines Mergers & Acquisitions Activity
Table 18. United States VS China Type 2 Diabetes Medicines Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Type 2 Diabetes Medicines Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Type 2 Diabetes Medicines Companies, Headquarters (States, Country)
Table 21. United States Based Companies Type 2 Diabetes Medicines Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Type 2 Diabetes Medicines Revenue Market Share (2019-2024)
Table 23. China Based Type 2 Diabetes Medicines Companies, Headquarters (Province, Country)
Table 24. China Based Companies Type 2 Diabetes Medicines Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Type 2 Diabetes Medicines Revenue Market Share (2019-2024)
Table 26. Rest of World Based Type 2 Diabetes Medicines Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Type 2 Diabetes Medicines Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Type 2 Diabetes Medicines Revenue Market Share (2019-2024)
Table 29. World Type 2 Diabetes Medicines Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Type 2 Diabetes Medicines Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Type 2 Diabetes Medicines Market Size by Type (2025-2030) & (USD Million)
Table 32. World Type 2 Diabetes Medicines Market Size by Channel, (USD Million), 2019 & 2023 & 2030
Table 33. World Type 2 Diabetes Medicines Market Size by Channel (2019-2024) & (USD Million)
Table 34. World Type 2 Diabetes Medicines Market Size by Channel (2025-2030) & (USD Million)
Table 35. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 36. Novo Nordisk Major Business
Table 37. Novo Nordisk Type 2 Diabetes Medicines Product and Services
Table 38. Novo Nordisk Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Novo Nordisk Recent Developments/Updates
Table 40. Novo Nordisk Competitive Strengths & Weaknesses
Table 41. Sanofi Basic Information, Manufacturing Base and Competitors
Table 42. Sanofi Major Business
Table 43. Sanofi Type 2 Diabetes Medicines Product and Services
Table 44. Sanofi Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Sanofi Recent Developments/Updates
Table 46. Sanofi Competitive Strengths & Weaknesses
Table 47. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 48. Eli Lilly Major Business
Table 49. Eli Lilly Type 2 Diabetes Medicines Product and Services
Table 50. Eli Lilly Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Eli Lilly Recent Developments/Updates
Table 52. Eli Lilly Competitive Strengths & Weaknesses
Table 53. Merck Basic Information, Manufacturing Base and Competitors
Table 54. Merck Major Business
Table 55. Merck Type 2 Diabetes Medicines Product and Services
Table 56. Merck Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Merck Recent Developments/Updates
Table 58. Merck Competitive Strengths & Weaknesses
Table 59. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 60. AstraZeneca Major Business
Table 61. AstraZeneca Type 2 Diabetes Medicines Product and Services
Table 62. AstraZeneca Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. AstraZeneca Recent Developments/Updates
Table 64. AstraZeneca Competitive Strengths & Weaknesses
Table 65. bayer Basic Information, Manufacturing Base and Competitors
Table 66. bayer Major Business
Table 67. bayer Type 2 Diabetes Medicines Product and Services
Table 68. bayer Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. bayer Recent Developments/Updates
Table 70. bayer Competitive Strengths & Weaknesses
Table 71. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 72. Boehringer Ingelheim Major Business
Table 73. Boehringer Ingelheim Type 2 Diabetes Medicines Product and Services
Table 74. Boehringer Ingelheim Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Boehringer Ingelheim Recent Developments/Updates
Table 76. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 77. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 78. Johnson & Johnson Major Business
Table 79. Johnson & Johnson Type 2 Diabetes Medicines Product and Services
Table 80. Johnson & Johnson Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Johnson & Johnson Recent Developments/Updates
Table 82. Johnson & Johnson Competitive Strengths & Weaknesses
Table 83. Takeda Basic Information, Manufacturing Base and Competitors
Table 84. Takeda Major Business
Table 85. Takeda Type 2 Diabetes Medicines Product and Services
Table 86. Takeda Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Takeda Recent Developments/Updates
Table 88. Takeda Competitive Strengths & Weaknesses
Table 89. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 90. Tonghua Dongbao Major Business
Table 91. Tonghua Dongbao Type 2 Diabetes Medicines Product and Services
Table 92. Tonghua Dongbao Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Tonghua Dongbao Recent Developments/Updates
Table 94. Tonghua Dongbao Competitive Strengths & Weaknesses
Table 95. United Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 96. United Pharmaceuticals Major Business
Table 97. United Pharmaceuticals Type 2 Diabetes Medicines Product and Services
Table 98. United Pharmaceuticals Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. United Pharmaceuticals Recent Developments/Updates
Table 100. United Pharmaceuticals Competitive Strengths & Weaknesses
Table 101. Ganli Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 102. Ganli Pharmaceutical Major Business
Table 103. Ganli Pharmaceutical Type 2 Diabetes Medicines Product and Services
Table 104. Ganli Pharmaceutical Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Ganli Pharmaceutical Recent Developments/Updates
Table 106. Ganli Pharmaceutical Competitive Strengths & Weaknesses
Table 107. Biocon Basic Information, Manufacturing Base and Competitors
Table 108. Biocon Major Business
Table 109. Biocon Type 2 Diabetes Medicines Product and Services
Table 110. Biocon Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Biocon Recent Developments/Updates
Table 112. Biocon Competitive Strengths & Weaknesses
Table 113. Conker Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 114. Conker Pharmaceuticals Major Business
Table 115. Conker Pharmaceuticals Type 2 Diabetes Medicines Product and Services
Table 116. Conker Pharmaceuticals Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. Conker Pharmaceuticals Recent Developments/Updates
Table 118. Conker Pharmaceuticals Competitive Strengths & Weaknesses
Table 119. Jiangsu Wanbang Basic Information, Manufacturing Base and Competitors
Table 120. Jiangsu Wanbang Major Business
Table 121. Jiangsu Wanbang Type 2 Diabetes Medicines Product and Services
Table 122. Jiangsu Wanbang Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Jiangsu Wanbang Recent Developments/Updates
Table 124. Jiangsu Wanbang Competitive Strengths & Weaknesses
Table 125. Geropharm Basic Information, Manufacturing Base and Competitors
Table 126. Geropharm Major Business
Table 127. Geropharm Type 2 Diabetes Medicines Product and Services
Table 128. Geropharm Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. Geropharm Recent Developments/Updates
Table 130. Geropharm Competitive Strengths & Weaknesses
Table 131. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 132. Wockhardt Major Business
Table 133. Wockhardt Type 2 Diabetes Medicines Product and Services
Table 134. Wockhardt Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. Wockhardt Recent Developments/Updates
Table 136. Wockhardt Competitive Strengths & Weaknesses
Table 137. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 138. Merck Serono Major Business
Table 139. Merck Serono Type 2 Diabetes Medicines Product and Services
Table 140. Merck Serono Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Merck Serono Recent Developments/Updates
Table 142. Merck Serono Competitive Strengths & Weaknesses
Table 143. Novartis Basic Information, Manufacturing Base and Competitors
Table 144. Novartis Major Business
Table 145. Novartis Type 2 Diabetes Medicines Product and Services
Table 146. Novartis Type 2 Diabetes Medicines Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. Novartis Recent Developments/Updates
Table 148. Novartis Competitive Strengths & Weaknesses
Table 149. Global Key Players of Type 2 Diabetes Medicines Upstream (Raw Materials)
Table 150. Global Type 2 Diabetes Medicines Typical Customers


List of Figures
Figure 1. Type 2 Diabetes Medicines Picture
Figure 2. World Type 2 Diabetes Medicines Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Type 2 Diabetes Medicines Total Revenue (2019-2030) & (USD Million)
Figure 4. World Type 2 Diabetes Medicines Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Type 2 Diabetes Medicines Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Type 2 Diabetes Medicines Revenue (2019-2030) & (USD Million)
Figure 13. Type 2 Diabetes Medicines Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 16. World Type 2 Diabetes Medicines Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 18. China Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 23. India Type 2 Diabetes Medicines Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Type 2 Diabetes Medicines by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Type 2 Diabetes Medicines Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Type 2 Diabetes Medicines Markets in 2023
Figure 27. United States VS China: Type 2 Diabetes Medicines Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Type 2 Diabetes Medicines Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Type 2 Diabetes Medicines Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Type 2 Diabetes Medicines Market Size Market Share by Type in 2023
Figure 31. Oral Hypoglycemic Medications
Figure 32. Insulin Injection
Figure 33. World Type 2 Diabetes Medicines Market Size Market Share by Type (2019-2030)
Figure 34. World Type 2 Diabetes Medicines Market Size by Channel, (USD Million), 2019 & 2023 & 2030
Figure 35. World Type 2 Diabetes Medicines Market Size Market Share by Channel in 2023
Figure 36. Hospital
Figure 37. Retail Pharmacy
Figure 38. World Type 2 Diabetes Medicines Market Size Market Share by Channel (2019-2030)
Figure 39. Type 2 Diabetes Medicines Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Novo Nordisk
Sanofi
Eli Lilly
Merck
AstraZeneca
bayer
Boehringer Ingelheim
Johnson & Johnson
Takeda
Tonghua Dongbao
United Pharmaceuticals
Ganli Pharmaceutical
Biocon
Conker Pharmaceuticals
Jiangsu Wanbang
Geropharm
Wockhardt
Merck Serono
Novartis
jiaGou

Add To Cart

gouMai

Buy Now